Overview

Accelerated Fractionation Radiotherapy (AFRT) Versus Concurrent Chemoradiotherapy (Crt) In Locally Advanced Head And Neck Squamous Cell Carcinoma

Status:
Unknown status
Trial end date:
2012-12-01
Target enrollment:
0
Participant gender:
All
Summary
The aim of this trial is to compare the accelerated fractionation radiotherapy and concurrent chemo-radiotherapy in locally advanced head and neck squamous cell carcinoma patients in terms of loco-regional control, toxicities and quality of life.
Phase:
Phase 2
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
All India Institute of Medical Sciences, New Delhi
Treatments:
Cisplatin
Criteria
Inclusion Criteria:

1. Age: 20 - 60 years old

2. Karnofsky performance scale score 70 or above

3. Biopsy proven squamous cell carcinomas (SCC) of oropharynx, larynx and hypopharynx

4. TNM stages- Stage III -IVB

5. Informed consent (in prescribed form under institutional guidelines)

Exclusion Criteria:

1. Lack of histopathological proof of malignancy (HNSCC)

2. Doubtful follow-up and/ or non-compliance

3. Previous oncologic therapy with surgery, radiotherapy or chemotherapy

4. Uncontrolled comorbid conditions e.g hypertension, diabetes mellitus, chronic
obstructive pulmonary disease, coronary artery disease